US Oncology migrated from a paper-based environment to the flexible iKnowMed system to improve physicians' ability to determine the best patient treatment regimen - from both a medical and cost perspective. iKnowMed's easy access to comprehensive patient data has enabled increased insight into treatment progress that facilitates intelligent and compassionate decision-making for providers - improving patient quality of life and reducing costs.
iKnowMed improves the practice's ability to ensure the safety of its patients by sending automatic, intelligent alerts to warn providers of adverse drug interactions or reactions. The Oracle-based iKnowMed system can identify viable patient candidates for clinical trials in a timely manner to support research initiatives for physicians participating in the US Oncology Research network.
US Oncology is leveraging the next-generation capabilities of its integrated EHR system to help the organisation build a care-focused on-line community for both patients and physicians. US Oncology also leveraged the capabilities of its Oracle E-Business Suite applications, including Oracle Supply Chain Planning and Oracle Warehouse Management, to deploy an ePedigree system that enables the company to track drugs from the product manufacturer through to delivery to each practice. The ePedigree system helps ensure that US Oncology maintains compliance with state regulations, and helps to prevent drug counterfeiting.
"The modern health care environment requires that providers balance delivering the highest quality of care while maintaining costs to patients and payers. Leveraging the flexible IT capabilities of Oracle Database, our iKnowMed electronic health records system provides the comprehensive patient information and treatment intelligence that enables physicians to assess the best course of treatment and effectively pursue and adjust treatment pathways to create a better experience for patients and clinicians, while continuing to reduce costs", stated Todd Schonherz, Chief Information Officer, US Oncology Inc.
US Oncology Inc., headquartered in The Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the United States' foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.
US Oncology uses its expertise to support every aspect of the cancer care delivery system - from drug development to distribution and outcomes measurement - enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1227 physicians operating in 468 locations, including 95 radiation oncology facilities in 39 states.
More Oracle company news can be found in the VMW June 2009 article The Ottawa Hospital transforms procurement and spend management with the Oracle E-Business Suite.